TAG:
commercial laboratories
UroCor, Inc.; Histology & AP.
By Robert Michel | From the Volume IV No. 17 – December 8, 1997 Issue
UROCOR, INC. MATCHES THERAPEUTICS WITH DIAGNOSTICS With the recent signing of a co-promotion agreement with Zeneca Pharmaceuticals, UroCor, Inc. is positioned to offer therapeutics as a complement to its diagnostic testing. Based in Oklahoma City, UroCor is a fast-growing c…
Hitting Financial Bottom
By R. Lewis Dark | From the Volume IV No. 16 – November 17, 1997 Issue
During the last three years, financial news from the clinical laboratory industry has generally been bad. Two things attracted the media’s attention. Multi-million dollar Medicare fraud settlements involving laboratories got widespread notoriety. Financial losses at public laboratories attracted le…
Tenet, SBCL Discussing 33 Hospital Lab Contract
By Robert Michel | From the Volume IV No. 16 – November 17, 1997 Issue
CEO SUMMARY: Tenet Healthcare’s decision to entertain proposals for improving laboratory operations in its Southern California division triggered a year-long discussion with national laboratories. If a deal results, it would represent one of the largest “re-engineering†projects bet…
Consolidation At Presbyterian Encourages Regional Strategy
By Robert Michel | From the Volume IV No. 15 – October 27, 1997 Issue
CEO SUMMARY: Presbyterian Laboratory Services represents one of the more advanced business models of laboratory consolidation found today in the United States. Owned by an integrated delivery system, the laboratory division serves six hospitals and a variety of outreach clients. Several e…
Consolidation Within The Diagnostics Industry
By R. Lewis Dark | From the Volume IV No. 14 – October 6, 1997 Issue
IN THIS ISSUE WE ARE GIVING COVERAGE to the acquisition of Coulter Corporation by Beckman Instruments, Inc. for an important reason. I believe this merger is first evidence of impending and significant changes to the diagnostics industry. During the next 18 to 24 m…
Diagnostic Companies About To Undergo Change
By Robert Michel | From the Volume IV No. 14 – October 6, 1997 Issue
CEO SUMMARY: Diagnostic companies are undergoing the same consolidation wave as commercial laboratories and hospitals. Beckman’s acquisition of Coulter provides an early example of how diagnostics companies will use acquisitions to create a comprehensive product line. Other surprising m…
Issues At Columbia/HCA Exist At Other Hospitals
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
CEO SUMMARY: Even as federal regulators attract big headlines in their investigation of Columbia/HCA, laboratory administrators in a variety of hospital settings may be surprised in the future to find federal investigators scrutinizing the billing practices at their institution. Columbiaâ…
Private Insurers Sue SmithKline, Feds Pursue Labs In Six States
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
FRAUD AND ABUSE for laboratory billing is an issue which refuses to disappear. Private insurers filed a lawsuit against SmithKline Beecham last Thursday, seeking unspecified damages related to overcharging for laboratory testing during the years 1989-1995. At the same time, news eme…
Innovative Approach Promises Integration of Clinical Lab Data
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
CEO SUMMARY: Any laboratory executive with several years in the business has confronted the limitations of laboratory information system (LIS) software. For a variety of reasons, LIS software seldom delivers the full range of benefits and cost-effectiveness sought by laboratories. But in …
Quest Diagnostics, Sonora Join Phoenix Operations
By Robert Michel | From the Volume IV No. 11 – August 4, 1997 Issue
CEO SUMMARY: When Quest Diagnostics Incorporated and Sonora Laboratory Sciences announced their joint venture, it confirmed that Quest Diagnostics is the first of the national laboratories to begin serious restructuring of its national network of regional laboratories. Such restructuring …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized